Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6171108 | Contraception | 2014 | 11 Pages |
Abstract
The 24-day regimen of drospirenone-containing combined OCs is associated with similar risks of venous and arterial thromboembolism, fatal outcomes, cancer, severe depression and other serious adverse events compared to 21-day regimens of drospirenone-containing combined OCs, OCs without drospirenone and LNGs.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jürgen Dinger, Kristina Bardenheuer, Klaas Heinemann,